191 related articles for article (PubMed ID: 26111904)
1. APOL1 and kidney disease: new insights leading to novel therapies.
Freedman BI
Am J Kidney Dis; 2015 Jul; 66(1):9-11. PubMed ID: 26111904
[No Abstract] [Full Text] [Related]
2. Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease.
Anyaegbu EI; Shaw AS; Hruska KA; Jain S
Pediatr Nephrol; 2015 Jun; 30(6):983-9. PubMed ID: 25530085
[TBL] [Abstract][Full Text] [Related]
3. Association of APOL1 Genotype with Renal Histology among Black HIV-Positive Patients Undergoing Kidney Biopsy.
Atta MG; Estrella MM; Skorecki KL; Kopp JB; Winkler CA; Wasser WG; Shemer R; Racusen LC; Kuperman M; Foy MC; Lucas GM; Fine DM
Clin J Am Soc Nephrol; 2016 Feb; 11(2):262-70. PubMed ID: 26668025
[TBL] [Abstract][Full Text] [Related]
4. APOL1 and kidney disease.
Pollak MR; Genovese G; Friedman DJ
Curr Opin Nephrol Hypertens; 2012 Mar; 21(2):179-82. PubMed ID: 22257798
[TBL] [Abstract][Full Text] [Related]
5. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.
Kopp JB; Nelson GW; Sampath K; Johnson RC; Genovese G; An P; Friedman D; Briggs W; Dart R; Korbet S; Mokrzycki MH; Kimmel PL; Limou S; Ahuja TS; Berns JS; Fryc J; Simon EE; Smith MC; Trachtman H; Michel DM; Schelling JR; Vlahov D; Pollak M; Winkler CA
J Am Soc Nephrol; 2011 Nov; 22(11):2129-37. PubMed ID: 21997394
[TBL] [Abstract][Full Text] [Related]
6. Association of trypanolytic ApoL1 variants with kidney disease in African Americans.
Genovese G; Friedman DJ; Ross MD; Lecordier L; Uzureau P; Freedman BI; Bowden DW; Langefeld CD; Oleksyk TK; Uscinski Knob AL; Bernhardy AJ; Hicks PJ; Nelson GW; Vanhollebeke B; Winkler CA; Kopp JB; Pays E; Pollak MR
Science; 2010 Aug; 329(5993):841-5. PubMed ID: 20647424
[TBL] [Abstract][Full Text] [Related]
7. Sequencing rare and common APOL1 coding variants to determine kidney disease risk.
Limou S; Nelson GW; Lecordier L; An P; O'hUigin CS; David VA; Binns-Roemer EA; Guiblet WM; Oleksyk TK; Pays E; Kopp JB; Winkler CA
Kidney Int; 2015 Oct; 88(4):754-63. PubMed ID: 25993319
[TBL] [Abstract][Full Text] [Related]
8. APOL1 and nephropathy progression in populations of African ancestry.
Freedman BI
Semin Nephrol; 2013 Sep; 33(5):425-32. PubMed ID: 24119848
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein L1 and Kidney Disease in African Americans.
Friedman DJ; Pollak MR
Trends Endocrinol Metab; 2016 Apr; 27(4):204-215. PubMed ID: 26947522
[TBL] [Abstract][Full Text] [Related]
10. Testing for High-Risk APOL1 Alleles in Potential Living Kidney Donors.
Riella LV; Sheridan AM
Am J Kidney Dis; 2015 Sep; 66(3):396-401. PubMed ID: 26049628
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein l1 and the genetic basis for racial disparity in chronic kidney disease.
Quaggin SE; George AL
J Am Soc Nephrol; 2011 Nov; 22(11):1955-8. PubMed ID: 21997393
[No Abstract] [Full Text] [Related]
12. Should kidney donors be genotyped for APOL1 risk alleles?
Freedman BI; Julian BA
Kidney Int; 2015 Apr; 87(4):671-3. PubMed ID: 25826538
[No Abstract] [Full Text] [Related]
13. Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
Hawkins GA; Friedman DJ; Lu L; McWilliams DR; Chou JW; Sajuthi S; Divers J; Parekh RS; Li M; Genovese G; Pollack MR; Hicks PJ; Bowden DW; Ma L; Freedman BI; Langefeld CD
Am J Nephrol; 2015; 42(2):99-106. PubMed ID: 26343748
[TBL] [Abstract][Full Text] [Related]
14. Genetics. Kidney disease is parasite-slaying protein's downside.
Leslie M
Science; 2010 Jul; 329(5989):263. PubMed ID: 20647431
[No Abstract] [Full Text] [Related]
15. Is it variants in the apolipoprotein l1 gene, or blood pressure control, that predicts progression of nondiabetic hypertensive nephropathy in African Americans?
Cohen DL; Townsend RR
J Clin Hypertens (Greenwich); 2013 Jul; 15(7):445-6. PubMed ID: 23815529
[No Abstract] [Full Text] [Related]
16. APOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans.
Gutiérrez OM; Judd SE; Irvin MR; Zhi D; Limdi N; Palmer ND; Rich SS; Sale MM; Freedman BI
Nephrol Dial Transplant; 2016 Apr; 31(4):602-8. PubMed ID: 26152403
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans.
Freedman BI; Langefeld CD; Murea M; Ma L; Otvos JD; Turner J; Antinozzi PA; Divers J; Hicks PJ; Bowden DW; Rocco MV; Parks JS
Nephrol Dial Transplant; 2011 Nov; 26(11):3805-10. PubMed ID: 21931123
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure.
Freedman BI; Julian BA; Pastan SO; Israni AK; Schladt D; Gautreaux MD; Hauptfeld V; Bray RA; Gebel HM; Kirk AD; Gaston RS; Rogers J; Farney AC; Orlando G; Stratta RJ; Mohan S; Ma L; Langefeld CD; Hicks PJ; Palmer ND; Adams PL; Palanisamy A; Reeves-Daniel AM; Divers J
Am J Transplant; 2015 Jun; 15(6):1615-22. PubMed ID: 25809272
[TBL] [Abstract][Full Text] [Related]
19. JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy.
Divers J; Núñez M; High KP; Murea M; Rocco MV; Ma L; Bowden DW; Hicks PJ; Spainhour M; Ornelles DA; Kleiboeker SB; Duncan K; Langefeld CD; Turner J; Freedman BI
Kidney Int; 2013 Dec; 84(6):1207-13. PubMed ID: 23677244
[TBL] [Abstract][Full Text] [Related]
20. African American living-kidney donors should be screened for APOL1 risk alleles.
Cohen DM; Mittalhenkle A; Scott DL; Young CJ; Norman DJ
Transplantation; 2011 Oct; 92(7):722-5. PubMed ID: 21878839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
